Omnicell Adds to Product Offerings in Canada Through Agreement with McKesson Canada

Arrangement Transitions Sales and Service of Former Aesynt Products to Omnicell

May 08, 2017

MOUNTAIN VIEW, Calif.

Omnicell, Inc., (NASDAQ: OMCL) a leading provider of medication and supply management solutions to healthcare systems and pharmacies, today announced it has reached an agreement with McKesson Canada under which direct sales of Omnicell’s former Aesynt® products will transition from McKesson Canada back to Omnicell. These products include central pharmacy robotics, AcuDose-Rx® automated dispensing cabinets and analytics. McKesson Canada will transition service of these products back to Omnicell as current customer support contracts expire.

“McKesson Canada will honor all existing customer contracts to ensure a smooth transition in partnership with Omnicell,” said Jean-Philippe Blouin, vice president Technology Solutions at McKesson Canada.  He added, “McKesson Canada will continue to be the exclusive distributor of PACMED® and PACVision® in both the hospital and retail pharmacy market in Canada.”  

“Omnicell has over 20 years of experience serving the Canadian market and we look forward to expanding the scope of our sales in Canada,” said J. Christopher Drew, president, North American Automation and Analytics at Omnicell. “Omnicell is committed to providing a smooth transition for the current customer base and delivering the same high quality of service they have been receiving from McKesson Canada.” 

Omnicell currently sells and services automated dispensing systems, pharmacy automation, and analytics products via a direct sales force in Canada. Moving forward, Canadian customers will benefit directly from Omnicell’s entire portfolio, including its new XT Automated Dispensing Cabinets introduced last December.